S&P revised outlook on MDC Partners (MDCA) to Negative
Tweet
Share
E-mailGet Alerts MDCA Hot Sheet
Join SI Premium – FREE
S&P revised outlook on MDC Partners (Nasdaq: MDCA) to Negative
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FOMC minutes from July 28-29th meeting
- Okta, Inc (OKTA) PT Raised to $170 at Cantor Fitzgerald Ahead of Q2 Results
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
Create E-mail Alert Related Categories
Credit RatingsRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
